Optus and Telstra squared off court on Friday over an allegedly misleading ad campaign for the second time in a week, this time over Telstra’s ‘Unlimited’ ad campaign.
IOOF shareholder gets discovery ok for possible class action
High Court grants ASIC leave to appeal Prime Trust case
Viterra loses third bid for Cargill talks with Allens over Joe White sale
Dorevitch Pathology settles union’s Fair Work case over lockout
Slater & Gordon vies for AMP shareholders with ‘best deal’ yet
BHP faces possible Australian class action over Brazil mine disaster
Shine joins AMP class action frenzy
DLA Piper’s patent advice to Neurim not privileged, court hears
Two generic drug makers are fighting for access to confidential documents related to amendments by Neurim Pharmaceutical of patents covering its sleep drug Circadin, telling the Federal Court on Thursday privilege had been waived after a phone conversation between the company’s founder and her lawyers from DLA Piper.